BioRestorative Therapies Statistics

Total Valuation

BRTX has a market cap or net worth of $12.53 million. The enterprise value is $1.79 million.

Market Cap	12.53M
Enterprise Value	1.79M

Important Dates

The last earnings date was Thursday, March 27, 2025, after market close.

Earnings Date	Mar 27, 2025
Ex-Dividend Date	n/a

Share Statistics

BRTX has 6.92 million shares outstanding. The number of shares has increased by 84.05% in one year.

Current Share Class	6.92M
Shares Outstanding	6.92M
Shares Change (YoY)	+84.05%
Shares Change (QoQ)	+0.05%
Owned by Insiders (%)	20.79%
Owned by Institutions (%)	4.07%
Float	4.32M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	35.04
Forward PS	5.08
PB Ratio	1.47
P/TBV Ratio	1.59
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	4.47
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.97

Current Ratio	2.97
Quick Ratio	2.91
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -96.89% and return on invested capital (ROIC) is -77.25%.

Return on Equity (ROE)	-96.89%
Return on Assets (ROA)	-58.03%
Return on Invested Capital (ROIC)	-77.25%
Return on Capital Employed (ROCE)	-135.44%
Revenue Per Employee	$36,455
Profits Per Employee	-$816,307
Employee Count	11
Asset Turnover	0.03
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +29.94% in the last 52 weeks. The beta is 63.72, so BRTX's price volatility has been higher than the market average.

Beta (5Y)	63.72
52-Week Price Change	+29.94%
50-Day Moving Average	1.97
200-Day Moving Average	1.71
Relative Strength Index (RSI)	51.30
Average Volume (20 Days)	61,263

Short Selling Information

The latest short interest is 405,160, so 5.85% of the outstanding shares have been sold short.

Short Interest	405,160
Short Previous Month	715,906
Short % of Shares Out	5.85%
Short % of Float	9.37%
Short Ratio (days to cover)	0.38

Income Statement

In the last 12 months, BRTX had revenue of $401,000 and -$8.98 million in losses. Loss per share was -$1.16.

Revenue	401,000
Gross Profit	372,928
Operating Income	-11.56M
Pretax Income	-6.96M
Net Income	-8.98M
EBITDA	-11.37M
EBIT	-11.56M
Loss Per Share	-$1.16

Full Income Statement

Balance Sheet

The company has $10.73 million in cash and n/a in debt, giving a net cash position of $10.73 million or $1.55 per share.

Cash & Cash Equivalents	10.73M
Total Debt	n/a
Net Cash	10.73M
Net Cash Per Share	$1.55
Equity (Book Value)	8.53M
Book Value Per Share	1.23
Working Capital	7.40M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$8.23 million and capital expenditures -$106,189, giving a free cash flow of -$8.34 million.

Operating Cash Flow	-8.23M
Capital Expenditures	-106,189
Free Cash Flow	-8.34M
FCF Per Share	-$1.20

Full Cash Flow Statement

Margins

Gross Margin	93.00%
Operating Margin	-2,881.59%
Pretax Margin	-2,239.25%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BRTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-84.05%
Shareholder Yield	n/a
Earnings Yield	-71.69%
FCF Yield	-66.56%

Analyst Forecast

The average price target for BRTX is $18.00, which is 894.48% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$18.00
Price Target Difference	894.48%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	243.92%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on October 27, 2021. It was a reverse split with a ratio of 0.00025:1.

Last Split Date	Oct 27, 2021
Split Type	Reverse
Split Ratio	0.00025:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2